Episode 47
Biotech Hangout
00:00
The Therapeutic Melanoma Partnership - Is That Really What They Think?
On Pfizer, I thought it was interesting to note that they had a slide on future revenues where they show how they're going to replace loss of revenues from patent explorations and COVID. And they pointed to $25 billion in revenues. That will come from BDD. So basically the idea is that they'regoing to acquire companies that are going to generate $25billion in revenues for them over the next few years. But speaking of how companies trade versus how they're doing, Pfizer had 100 billion in revenues, which is an all time high for them. They traded down. Don't do you have any comments on anything that was said? Earnings, anything? No,
Transcript
Play full episode
